Exova is covered by various financial analysts and our understanding of current market consensus is as follows:

FY 2016
Revenue £m Adjusted EBITA £m (1) Adjusted EPS p (2)
Mean 329.3 50.1 12.5
High 331.2 50.8 12.8
Low 325.0 49.4 12.3
No. of analysts 5 5 5
FY 2017
Revenue £m Adjusted EBITA £m (1) Adjusted EPS p (2)
Mean 333.9 50.9 12.9
High 337.8 51.4 13.0
Low 327.0 50.0 12.7
No. of analysts 5 5 5

Last updated: 01-03-2017


1) Before restructuring costs, acquisition and integration costs and impairment of assets.

2) Before separately disclosed items.

This analysis is a collation of forecasts which have been provided to us by registered investment analysts and are, as such, publicly available information. Exova has not endorsed or commented on any individual forecasts, nor do we intend to do so in future.

It should be noted that forecasts are by definition forward looking and are therefore subject to risks and uncertainties that may materially affect eventual results. Neither Exova nor any subsidiary undertaking or any director, officer or employee of Exova accepts any responsibility for the accuracy of the forecasts used in this analysis and therefore shall have no liability whatsoever for the consequences of any reliance or actions taken or not taken based on any of the information in the analysis. Nothing in this analysis should be taken as a recommendation to buy or sell shares in Exova or to take any other action or place any reliance on the analysis.

Although we will endeavour to keep this information updated, we assume no obligation to update or revise such information to reflect circumstances existing after the date hereof.